Wednesday, September 02, 2020 8:19:55 AM
Cannot view this video? Visit:
Nextleaf has completed successful scale trials for a variety of market-validated product formats manufactured with the Company's patent pending technology.
Ten years of collective R&D has resulted in a proprietary delivery system that has been adapted to cannabis, increasing bioavailability through micro and nano emulsification to deliver rapid onset of THC, CBD, and other cannabinoids. OILS currently has a pending to issued patent allowance success rate of 100%, with over 40 issued patents globally.
The commercial launch of this innovative technology comes within a year of the legalization of cannabis 2.0 products across Canada. Rapid Emulsion Technology by OILST can be used in a variety of infused product formulations including ready-to-drink beverages and ingestible concentrates.
Nextleaf has commenced further innovation and development of a powdered cannabinoids product based on the core Rapid Emulsion Technology by OILST. Using Nextleaf's high purity distillate, alongside microscopic amounts of natural carrier oils and food-grade emulsifiers, the unique droplet structure allows the final ingredient to be virtually tasteless, odorless, and achieve optical transparency through uniform and complete dispersion of the particle into water.
"Our patent pending technology provides exceptional stability when developing a wide range of infused products such as edibles and beverages. Being able to accommodate different flavors, potency, and pH values - with ease - provides greater flexibility and speed-to-market advantages during product development," said Emma Andrews, Director of Marketing at Nextleaf.
Rapid Emulsion Technology by OILST delivers on an existing consumer need for value-added products beyond combustible cannabis that are portable and offer discreet methods of consumption with reliable and predictable onset. This technology extends OILS' range of services and depth of expertise along the value-added product spectrum. Complimenting Nextleaf's demonstrated excellence in efficiently processing high purity distillate, Rapid Emulsion Technology by OILST will be available to B2B partners as an additional service alongside toll processing, bulk ingredient sales, IP licensing, and R&D.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM